US Patent 10973817 Pharmaceutical compounds
Patent 10973817 was granted and assigned to Sentinel Oncology Limited on April, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+219 characters)
Article
Patent abstract
This invention relates to compounds that inhibit or modulate the activity of Chk-1 kinase. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds.
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Cong Hung Vo0
David Winter Walker0
Francine Farouz0
Richard Justin Boyce0
Robert George Boyle0
Scott Peterson0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109738170
Date of Patent
April 13, 2021
0Patent Application Number
159949470
Date Filed
May 31, 2018
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10973817 Pharmaceutical compounds
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10973817
Date of patent
April 13, 2021
Patent application number
15994947
Date Filed
May 31, 2018
Patent citations
Patent primary examiner
Find more entities like US Patent 10973817 Pharmaceutical compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.